XTX Topco’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $274K | Sell |
33,918
-48,358
| -59% | -$391K | 0.01% | 1501 |
|
2025
Q1 | $689K | Buy |
82,276
+43,221
| +111% | +$362K | 0.04% | 789 |
|
2024
Q4 | $309K | Buy |
39,055
+16,845
| +76% | +$133K | 0.03% | 1179 |
|
2024
Q3 | $185K | Sell |
22,210
-10,062
| -31% | -$83.7K | 0.01% | 1464 |
|
2024
Q2 | $205K | Sell |
32,272
-2,130
| -6% | -$13.5K | 0.02% | 1223 |
|
2024
Q1 | $208K | Sell |
34,402
-14,990
| -30% | -$90.8K | 0.03% | 1140 |
|
2023
Q4 | $300K | Buy |
49,392
+7,114
| +17% | +$43.2K | 0.07% | 620 |
|
2023
Q3 | $178K | Buy |
42,278
+9,743
| +30% | +$41.1K | 0.03% | 1054 |
|
2023
Q2 | $101K | Sell |
32,535
-142,965
| -81% | -$443K | 0.02% | 1165 |
|
2023
Q1 | $244K | Sell |
175,500
-16,002
| -8% | -$22.2K | 0.05% | 803 |
|
2022
Q4 | $381K | Buy |
+191,502
| New | +$381K | 0.08% | 435 |
|
2022
Q1 | – | Sell |
-23,742
| Closed | -$114K | – | 660 |
|
2021
Q4 | $114K | Buy |
23,742
+11,369
| +92% | +$54.6K | 0.06% | 447 |
|
2021
Q3 | $66K | Sell |
12,373
-12,130
| -50% | -$64.7K | 0.02% | 586 |
|
2021
Q2 | $125K | Buy |
+24,503
| New | +$125K | 0.04% | 631 |
|